Roflo, Crestila .

HRN: 21-92-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
CEFUROXIME 500MG (TAB)
09/13/2022
09/20/2022
PO
1tab
Q12H
TMSAF
Waiting Final Action 
09/13/2022
METRONIDAZOLE 500MG (TAB)
09/13/2022
09/20/2022
PO
1tab
Q8H
TMSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: